Log In
BCIQ
Print this Print this
 

D-3263 HCl

Also known as: D3263

  Manage Alerts
Collapse Summary General Information
Company Valeant Pharmaceuticals International Inc.
DescriptionOrally bioavailable small molecule Trp-p8 agonist
Molecular Target Trp-p8 ion channel
Mechanism of ActionTransient receptor potential cation channel agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationSolid tumors
Indication DetailsTreat advanced solid tumors; Treat solid tumors that are refractory to standard therapies
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today